Redsense Medical AB (publ)
RDSNF
$0.51
-$0.54-51.43%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 457.60K | 1.18M | 483.00K | 871.80K | 166.80K |
| Total Other Revenue | -- | -- | -- | -- | -100.00 |
| Total Revenue | 457.60K | 1.18M | 483.00K | 871.80K | 166.70K |
| Cost of Revenue | 239.70K | 428.70K | 202.50K | 311.50K | 60.60K |
| Gross Profit | 217.90K | 747.20K | 280.50K | 560.40K | 106.10K |
| SG&A Expenses | 328.30K | 392.70K | 462.60K | 562.50K | 451.70K |
| Depreciation & Amortization | 1.50K | 1.60K | 1.60K | 1.60K | 1.50K |
| Other Operating Expenses | 183.80K | -159.20K | 130.40K | -61.00K | -91.60K |
| Total Operating Expenses | 753.30K | 663.80K | 797.20K | 814.60K | 422.30K |
| Operating Income | -295.70K | 512.10K | -314.20K | 57.20K | -255.50K |
| Income Before Tax | -295.50K | 521.80K | -314.10K | 58.50K | -254.00K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -295.50K | 521.80K | -314.10K | 58.50K | -254.00K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -295.50K | 521.80K | -314.10K | 58.50K | -254.00K |
| EBIT | -295.70K | 512.10K | -314.20K | 57.20K | -255.50K |
| EBITDA | -294.20K | 513.70K | -312.60K | 58.80K | -254.00K |
| EPS Basic | -0.02 | 0.03 | -0.02 | 0.00 | -0.02 |
| Normalized Basic EPS | -0.01 | 0.02 | -0.01 | 0.00 | -0.01 |
| EPS Diluted | -0.02 | 0.03 | -0.02 | 0.00 | -0.02 |
| Normalized Diluted EPS | -0.01 | 0.02 | -0.01 | 0.00 | -0.01 |
| Average Basic Shares Outstanding | 16.59M | 16.56M | 16.44M | 15.63M | 13.89M |
| Average Diluted Shares Outstanding | 16.59M | 16.56M | 16.44M | 15.63M | 13.89M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |